CEN Biotech, Inc.
CEN Biotech, Inc. (CENBF) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · CENBF · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
CENBF insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Purdy Rick Leigh SVP of Deals and Acquisitions | Dec 6, 2021 | Award | 2,500,000 | — | — | 2.81M | Form 4 ↗ |
Tarrabain Alex Chief Financial Officer | Jun 16, 2021 | J-Other | 3,000 | — | — | 2.78M | Form 4 ↗ |
Tarrabain Alex Chief Financial Officer | Jun 25, 2021 | Award | 1,000,000 | — | — | 2.78M | Form 4 ↗ |
Aubrey de Lavenu Harold Andre director | Apr 2, 2021 | Award | 1,041,250 | — | — | 1.62M | Form 4 ↗ |
Strilchuck Donald director | Apr 2, 2021 | Award | 341,250 | — | — | 1.36M | Form 4 ↗ |
Saadikh Usamakh director | Apr 2, 2021 | Award | 1,000,000 | — | — | 1.02M | Form 4 ↗ |
Boswell Richard Senior Executive VP | Jan 27, 2021 | Sale | 6,250 | $0.80 | $5.0K | 6.00M | Form 4 ↗ |
Boswell Richard Senior Executive VP | Jan 26, 2021 | Sale | 37,500 | $0.40 | $15.0K | 6.00M | Form 4 ↗ |
Boswell Richard Senior Executive VP | Apr 2, 2021 | Award | 2,185,679 | — | — | 6.00M | Form 4 ↗ |
Payne Brian Vice President | Apr 2, 2021 | Award | 1,435,000 | — | — | 2.21M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CEN Biotech, Inc. (CENBF) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold CENBF stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
CENBF ownershipCEN Biotech, Inc. (CENBF) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.